USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 25, 2022 (est) | Dec 31, 2021 | - | - | $0.45 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 25, 2022 (est) | Dec 31, 2021 | - | - | $27.15M |
Co-Diagnostics, Inc's next estimated earnings date (based on same quarter last year's date) is Mar 25, 2022 for the fiscal quarter ending Dec 31, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $0.52 | $0.13 | $1.07 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $0.52 | $0.48 | $0.59 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $83.76M | $60.27M | $118.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $0.21 | - | - |
| Aug 12, 2021 | Jun 2021 | $0.22 | $0.33 | 50.00% |
| May 13, 2021 | Mar 2021 | $0.20 | $0.26 | 30.00% |
| Mar 25, 2021 | Dec 2020 | $0.49 | $0.45 | -7.22% |
| Nov 16, 2020 | Sep 2020 | $0.71 | $0.53 | -24.82% |
| Aug 13, 2020 | Jun 2020 | $0.65 | $0.43 | -33.85% |
| May 14, 2020 | Mar 2020 | $-0.04 | $-0.05 | -25.00% |
| Mar 30, 2020 | Dec 2019 | $-0.09 | $-0.09 | -5.88% |
| Nov 12, 2019 | Sep 2019 | $-0.08 | $-0.10 | -33.33% |
| Aug 14, 2019 | Jun 2019 | $-0.06 | $-0.08 | -45.45% |
| May 14, 2019 | Mar 2019 | $-0.08 | $-0.09 | -12.50% |
| Dec 31, 2018 | Dec 2018 | $-0.13 | $-0.15 | -15.38% |
| Nov 14, 2018 | Sep 2018 | - | $-0.13 | - |
| Aug 10, 2018 | Jun 2018 | - | $-0.11 | - |
| May 14, 2018 | Mar 2018 | - | $-0.11 | - |
| Mar 28, 2018 | Dec 2017 | - | $-0.12 | - |
| Sep 30, 2017 | Sep 2017 | - | $-0.33 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $1.54 | $1.36 | -11.69% |
| Mar 30, 2020 | Dec 2019 | $-0.36 | $-0.36 | - |
| Dec 31, 2018 | Dec 2018 | $-0.48 | $-0.50 | - |
| Mar 28, 2018 | Dec 2017 | - | $-0.45 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 15, 2021 | Sep 2021 | $24.32M | - | - |
| Aug 12, 2021 | Jun 2021 | $27.36M | $27.36M | 1.00% |
| May 13, 2021 | Mar 2021 | $19.89M | $20.02M | 1.01% |
| Mar 25, 2021 | Dec 2020 | $24.99M | $27.15M | 1.09% |
| Nov 16, 2020 | Sep 2020 | $32.79M | $21.82M | 0.67% |
| Aug 13, 2020 | Jun 2020 | $26.45M | $24.04M | 0.91% |
| May 14, 2020 | Mar 2020 | $620.00K | $1.55M | 2.50% |
| Mar 30, 2020 | Dec 2019 | $100.00K | $108.57K | 1.09% |
| Nov 12, 2019 | Sep 2019 | $310.00K | $41.43K | 0.13% |
| Aug 14, 2019 | Jun 2019 | $520.00K | $61.57K | 0.12% |
| May 14, 2019 | Mar 2019 | $4.00K | $10.82K | 2.71% |
| Dec 31, 2018 | Dec 2018 | $10.00K | $10.82K | 1.08% |
| Nov 14, 2018 | Sep 2018 | - | $9.70K | - |
| Aug 10, 2018 | Jun 2018 | - | $9.70K | - |
| May 14, 2018 | Mar 2018 | - | $9.70K | - |
| Mar 28, 2018 | Dec 2017 | - | $2.60K | - |
| Sep 30, 2017 | Sep 2017 | - | $2.60K | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $72.37M | $74.55M | 3.02% |
| Mar 30, 2020 | Dec 2019 | $210.00K | $214.97K | 2.37% |
| Dec 31, 2018 | Dec 2018 | $40.00K | $39.91K | -0.22% |
| Mar 28, 2018 | Dec 2017 | - | $7.66K | - |
CODX's next estimated earnings date (based on same quarter last year's report date) is Mar 25, 2022 for the fiscal quarter ending Dec 31, 2021.
Co-Diagnostics, Inc's previous earnings date was Nov 15, 2021 for its fiscal quarter ended Sep 30, 2021.
Co-Diagnostics, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.
CODX's earnings per share (EPS) was $1.36, missing the consensus analysts forecast of $1.54 by -11.69% , and higher than the previous year's EPS (Dec 2019) by -477.78%.
Revenues were $74.55M, better than the forecast of $72.37M by 3.02%, and up by 34579.90% from previous year's revenue.
The company reported a net income of $42.48M.
Co-Diagnostics, Inc reported a free cash flow of $27.39M for its fiscal year, compared to $-5.64M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
